LPL Financial’s Guardant Health GH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $14.7M | Buy |
82,534
+36,435
| +79% | +$5.95M | ﹤0.01% | 1849 |
|
|
2026
Q2 | $6.92M | Sell |
46,099
-2,723
| -6% | -$296K | ﹤0.01% | 2496 |
|
|
2026
Q1 | $4.51M | Sell |
48,822
-32,325
| -40% | -$3.25M | ﹤0.01% | 2718 |
|
|
2025
Q4 | $8.29M | Buy |
81,147
+55,746
| +219% | +$4.99M | ﹤0.01% | 2087 |
|
|
2025
Q3 | $1.59M | Buy |
25,401
+140
| +0.6% | +$7.62K | ﹤0.01% | 3541 |
|
|
2025
Q2 | $1.31M | Buy |
25,261
+6,060
| +32% | +$271K | ﹤0.01% | 3504 |
|
|
2025
Q1 | $818K | Buy |
19,201
+2,773
| +17% | +$120K | ﹤0.01% | 3729 |
|
|
2024
Q4 | $502K | Sell |
16,428
-11,422
| -41% | -$321K | ﹤0.01% | 4083 |
|
|
2024
Q3 | $639K | Buy |
27,850
+11,659
| +72% | +$330K | ﹤0.01% | 3792 |
|
|
2024
Q2 | $468K | Sell |
16,191
-2,056
| -11% | -$47.9K | ﹤0.01% | 3932 |
|
|
2024
Q1 | $376K | Sell |
18,247
-41,243
| -69% | -$884K | ﹤0.01% | 4022 |
|
|
2023
Q4 | $1.61M | Sell |
59,490
-4,476
| -7% | -$117K | ﹤0.01% | 2621 |
|
|
2023
Q3 | $1.9M | Sell |
63,966
-2,031
| -3% | -$71.4K | ﹤0.01% | 2332 |
|
|
2023
Q2 | $2.36M | Buy |
65,997
+1,203
| +2% | +$34.5K | ﹤0.01% | 2103 |
|
|
2023
Q1 | $1.52M | Sell |
64,794
-3,275
| -5% | -$93.5K | ﹤0.01% | 2386 |
|
|
2022
Q4 | $1.85M | Buy |
68,069
+5,135
| +8% | +$235K | ﹤0.01% | 2129 |
|
|
2022
Q3 | $3.39M | Sell |
62,934
-3,965
| -6% | -$204K | ﹤0.01% | 1632 |
|
|
2022
Q2 | $2.7M | Buy |
66,899
+1,065
| +2% | +$52.8K | ﹤0.01% | 1794 |
|
|
2022
Q1 | $4.36M | Sell |
65,834
-5,260
| -7% | -$360K | ﹤0.01% | 1530 |
|
|
2021
Q4 | $7.11M | Sell |
71,094
-942
| -1% | -$97.4K | 0.01% | 1225 |
|
|
2021
Q3 | $9M | Buy |
72,036
+16,372
| +29% | +$1.95M | 0.01% | 1020 |
|
|
2021
Q2 | $6.91M | Buy |
55,664
+1,751
| +3% | +$236K | 0.01% | 1128 |
|
|
2021
Q1 | $8.23M | Sell |
53,913
-8,211
| -13% | -$1.24M | 0.01% | 933 |
|
|
2020
Q4 | $8.01M | Buy |
62,124
+12,933
| +26% | +$1.49M | 0.01% | 855 |
|
|
2020
Q3 | $5.5M | Sell |
49,191
-193
| -0.4% | -$17.7K | 0.01% | 904 |
|
|
2020
Q2 | $4.01M | Buy |
49,384
+5,664
| +13% | +$456K | 0.01% | 989 |
|
|
2020
Q1 | $3.04M | Buy |
43,720
+20,614
| +89% | +$1.58M | 0.01% | 959 |
|
|
2019
Q4 | $1.81M | Buy |
23,106
+5,499
| +31% | +$396K | ﹤0.01% | 1420 |
|
|
2019
Q3 | $1.12M | Buy |
17,607
+2,506
| +17% | +$221K | ﹤0.01% | 1641 |
|
|
2019
Q2 | $1.3M | Buy |
15,101
+4,245
| +39% | +$324K | ﹤0.01% | 1537 |
|
|
2019
Q1 | $833K | Buy |
+10,856
| New | +$602K | ﹤0.01% | 1782 |
|
Other funds holding GH
LPL Financial's GH Position: Q3 2026 in Review
LPL Financial increased its Guardant Health (GH) stake by 79% in Q3 2026, buying an estimated $5.95M and bringing the position to 82,534 shares worth $14.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1849.
LPL Financial first reported a position in GH in Q1 2019 and has held it in 31 quarters since. 278 funds tracked by Wall St. Rank hold GH as of Q3 2026.
- LPL Financial held 82,534 shares of Guardant Health worth $14.7M as of Q3 2026.
- LPL Financial bought 36,435 Guardant Health shares in Q3 2026, an estimated $5.95M.
- Guardant Health made up ﹤0.01% of LPL Financial's portfolio in Q3 2026, its #1849 holding.
- LPL Financial first reported a position in Guardant Health in Q1 2019 and has held it in 31 quarters since.
- 278 funds tracked by Wall St. Rank held Guardant Health as of Q3 2026.
Based on LPL Financial's 13F filing for Q3 2026, filed 6 Nov 2026.